BOBS

BOBS remains in a Stage 2 advancing uptrend supported by rising EMAs, but recent mid-July exhaustion candles at resistance coupled with overbought RSI and price extended above the EMAs signal near-term fatigue. Execution favors deferring entry and stalking for a pullback into the rising 9/21 EMA zone near the prior consolidation low, awaiting signs of acceptance before engaging.

• ↑Aggressive footprint growth targeting 500 stores by 2035, with new units averaging $9M in annual sales.
• ↑Q1 2026 revenue rose 8.5% YoY to $578.1M; comparable sales +1.2% and e-commerce +13.5%.
• ↓Forward P/E of 18x vs. 12x industry average suggests stretched valuation.